Connect your AI

Avanos Medical AVNS 2028

2028 at other companies

Cardinal HealthCAH

——

IAR

Integra LifeSciencesIART

——

Option Care Health, Inc.OPCH

——

ITG

Integer HoldingsITGR

——

AbbottABT

——

Other financials

Income statement

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Avanos Medical's 2028?: Avanos Medical (AVNS) reported 2028 of $0 in Q1 2026.
How has Avanos Medical's 2028 changed year-over-year?: Avanos Medical's 2028 decreased by 100.0% year-over-year, from $90.6M to $0.